Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Vertex Pharmaceuticals

$100 Invested In Vertex Pharmaceuticals 15 Years Ago Would Be Worth This Much

Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past 15 years by 7.35% on an annualized basis producing an average annual return of 15.26%. Currently, Vertex Pharmaceuticals has a market capitalization of $67.63 billion.

Dow Jones Rallies After March Jobs Report Miss; Treasury Yields Surge

Dow Jones Rallies After March Jobs Report Miss; Treasury Yields Surge

The Dow Jones Industrial Average rallied Friday after the March jobs report miss. The 10-year Treasury yield surged.

Investors Business Daily

Dow Jones Falls As Biden Taps Emergency Oil, Inflation Gauge Hits 39-Year High; Pharma Leader Pops

Dow Jones Falls As Biden Taps Emergency Oil, Inflation Gauge Hits 39-Year High; Pharma Leader Pops

The Dow Jones fell as President Joe Biden tapped the nation's emergency oil reserves. The Fed's favorite inflation gauge spiked.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Dow Jones Continues To Pull Back After Recent Rally; Investors Await Biden's Release Of Oil Reserves

Elsewhere, Paychex rose over 1% and moved above a proper buy point.

Investors Business Daily

Vertex Touts Positive Data From Mid-Stage Study Of Its Non-Opioid Pain Drug

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) released positive results from two Phase 2 post-operative trials for its non-opioid program, VX-548. One trial looked at patients who had just received a bunionectomy (Correcting the deformity of toes & foot), the other in patients who received abdominoplasty (tummy tuck). Vertex said that within 48 hours of surgery,…

Stock Market Falls As Biden To Release Oil Reserves; Key Inflation Rate Rises

The stock market traded lower as President Biden prepared to release oil reserves, sending oil prices lower.

Investors Business Daily

Dow Jones Falls As Biden Touts This Tax Hike; Tesla Soars Despite Covid Shutdown; AMC Stock Explodes

The Dow Jones fell after President Biden unveiled tax hikes. Tesla stock soared on split news. Microsoft was up while AMC stock exploded.

Investors Business Daily

inkl

Read news from The Economist, FT, and more,
with one subscription

IBD Screen Of The Day: 3 Stocks Near Buy Points With Rising Profit Estimates

IBD Screen Of The Day: 3 Stocks Near Buy Points With Rising Profit Estimates

Vertex Pharmaceuticals has been outperforming and ranks second in the biotech industry group.

Investors Business Daily

$1000 Invested In Vertex Pharmaceuticals 5 Years Ago Would Be Worth This Much

$1000 Invested In Vertex Pharmaceuticals 5 Years Ago Would Be Worth This Much

Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past 5 years by 9.35% on an annualized basis.

UnitedHealth, Vertex Lead Five Stocks Looking Healthy In A Weak Market

UnitedHealth, Vertex Lead Five Stocks Looking Healthy In A Weak Market

UnitedHealth and Vertex Pharmaceuticals are among five medical stocks with healthy action in a weak market.

Investors Business Daily

This Biopharmaceutical Company Has A Better 1-Year Return Than Tesla, Apple, Starbucks, Nvidia And Microsoft

This Biopharmaceutical Company Has A Better 1-Year Return Than Tesla, Apple, Starbucks, Nvidia And Microsoft

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) creates new possibilities via medicine to cure diseases and improve people's lives, and over the past year, marked gains in investors’ portfolios.

Recap: Vertex Pharmaceuticals Q4 Earnings

Recap: Vertex Pharmaceuticals Q4 Earnings

Vertex Pharmaceuticals (NASDAQ:VRTX) reported its Q4 earnings results on Wednesday, January 26, 2022 at 04:01 PM. Here's what investors need to know about the announcement.

Vertex Pharma Nears Year-High As Bullish Outlook, Pipeline Promise Spark Shares

Vertex Pharma Nears Year-High As Bullish Outlook, Pipeline Promise Spark Shares

Vertex Pharmaceuticals issued a bullish 2022 outlook, leading VRTX stock to approach a 12-month high early Thursday.

Investors Business Daily

Where Vertex Pharmaceuticals Stands With Analysts

Where Vertex Pharmaceuticals Stands With Analysts

Over the past 3 months, 6 analysts have published their opinion on Vertex Pharmaceuticals (NASDAQ:VRTX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Get all your
news in one place.

100’s of premium titles.
One news app.

1 … 4 5 6 7

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

IBD MarketSmith

IBD Leaderboard

Occidental Petroleum

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play